These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7580266)

  • 21. Immunosuppressive treatment of Graves' ophthalmopathy.
    Wiersinga WM
    Thyroid; 1992; 2(3):229-33. PubMed ID: 1422236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
    Szucs-Farkas Z; Toth J; Kollar J; Galuska L; Burman KD; Boda J; Leovey A; Varga J; Ujhelyi B; Szabo J; Berta A; Nagy EV
    Thyroid; 2005 Feb; 15(2):146-51. PubMed ID: 15753674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
    Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
    AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
    Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles.
    Majos A; Pajak M; Grzelak P; Stefańczyk L
    Med Sci Monit; 2007 May; 13 Suppl 1():44-8. PubMed ID: 17507884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
    Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
    Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
    Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy.
    Willinsky RA; Arenson AM; Hurwitz JJ; Szalai J
    J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging].
    Hiromatsu Y; Eguchi H; Tani J
    Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motility disturbances in Graves' ophthalmopathy.
    de Waard R; Koornneef L; Verbeeten B
    Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
    Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
    Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation Between Optical Coherence Tomography and Magnetic Resonance Imaging of Rectus Muscle Thickness Measurements in Graves' Ophthalmopathy.
    De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Merino-Menéndez S; Duque-Muñoz M; Gómez-de-Liaño R
    J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):319-326. PubMed ID: 31545866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].
    Sillaire I; Ravel A; Dalens H; Garcier JM; Boyer L
    J Radiol; 2003 Feb; 84(2 Pt 1):139-42. PubMed ID: 12717285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 131 iodine therapy on the course of Graves' ophthalmopathy: a quantitative analysis of extraocular muscle volumes using orbital magnetic resonance imaging.
    Gupta MK; Perl J; Beham R; Sheeler LR; Foster JA; Gliga M; Mcbride N; Faiman MR; Mehta AE; Dattatreya R; Faiman C
    Thyroid; 2001 Oct; 11(10):959-65. PubMed ID: 11716044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response.
    Polito E; Leccisotti A
    Ophthalmologica; 1995; 209(4):182-6. PubMed ID: 8545089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.
    Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
    Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.